Article PDF
Avoid common mistakes on your manuscript.
Literatur
Hörnlimann B, Riesner D, Kretzschmar H (2001) Prionen und Prionkrankheiten. Walter de Gruyter, Berlin New York
Prusiner SB (2001) Shattuck lecture — neurodegenerative diseases and prions. N Engl J Med 344:1516–1526
Brown P, Preece JP, Brandel T et al. (2000) Iatrogenic Creutzfeldt-Jakob disease at the millenium. Neurology 55:1075–1081
Hill AF, Desbruslais M, Joiner S et al. (1997) The same prion strain causes vCJD and BSE. Nature 389:448–449
Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmission to mice indicate that new variant CJD is caused by the BSE agent. Nature 389:498–501
Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D (1974) Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290:693–693
Adams DH, Edgar WM (1978) Transmission of agent of Creutzfeldt-Jakob disease. Br Med J 1:987
Gibbs CJ Jr., Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC (1994) Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 57:757–758
Heckmann JG, Lang CJ, Petruch F, Druchky A, Erb C, Brown P, Neudorfer B (1997) Transmission of CJD via corneal transplant. J Neurol Neurosurg Psychiatry 63:388–390
Will RG, Ironside JW, Zeidler M (1996) A new variant of Creutzfeldt-Jacob disease in the UK. Lancet 347:921–925
Brown P, Will RG, Bradley R, Asher DM, Detwiler L (2001) Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution and current concerns. Emerg Infect Dis 7:6–16
Lasmézas CI, Fournier JG, Nouvel V, Boe H, Marce D, Lamoury F, Kopp N, Hauw JJ, Ironside J, Bruce M, Dormont D, Deslys JP (2001) Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA 98:4142–4147
Hilton DA, Fathers E, Edwards P, Ironside JW, Zajucek J (1998) Prion immunoreactivity in appendix before clinical onset of variant CJD. Lancet 352:703–704
Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tollev N, Bell JE, Spencer M, King A, Al-Saarj S, Ironside JW, Lantos PL, Collinge J (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183–189
Bruce ME, McConnell I, Will RG, Ironside JW (2001) Detection of variant CJD infectivity in extraneural tissues. Lancet 358:208–209
Ironside JW, Hilton DA, Ghani A, Johnston NJ, Conyers L, McCardle LM, Best D (2000) Retrospective study on prion-protein accumulation in tonsil and appendix tissues. Lancet 355:1693–1694
Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jacob disease using a highly sensitive immunoblotting assay. Lancet 358:171–180
Schreuder BEC, Geertsma RE, van Keulen LJ, van Asten JA, Enthoven P, Oberthur RC, de Koeijer AA, Osterhaus AD (1998) Studies on the efficacy of hyperbaric rendering procedures in inactivating bovine spongiform encephalopathy (BSE) and scrapie agents. Vet Rec 142:474–480
Rutala WA, Weber DJ (2001) Creutzfeldt-Jakob disease. Recommendations for disinfection and sterilization. Clin Infect Dis 32:1348–1356
Taylor DM (1999) Inactivation of prions by physical and chemical means. J Hospital Infect 43 [Suppl]:69–76
Taylor DM (2000) Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159:10–17
Block S 2001 Disinfection, sterilization,and preservation, 5th edn. Verlag Lippincolt Williams u.Wilkins
Risk assessment for transmission of variant CJD via surgical instruments: a modelling approach and numerical scenarios. Economics and Operational Research Division Department of Health, December 2000, London, http://www.doh.gov.uk/cjd/riskassessmentsi.htm
Laurenson IF, Whyte AS, Fox C, Babb JR (1999) Contaminated surgical instruments and variant Creutzfeldt-Jakob disease. Lancet 354:1823
Taylor DM, Fraser JR (2000) Letters to the editor/The potential risk of transmitting vCJD through surgery. J Hosp Inf 44:318–319
Axon A, Beilenhoff U, Bramble MG et al. (2001) Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy. Endoscopy 33:1070–1080
Shmakow AN, Gosh S (2001) Prion proteins and the gut: une liaison dangereuse? Gut 48:443–447
Kretzschmar HA (2001) BSE und die neue Variante der Creutzfeldt-Jakob-Krankheit. Dtsch Ärztebl 98:A; 40:2576–2583
Manuelidis EE, Angelo JN, Gorgacz EJ, Kim JH, Manuelidis L (1977) Experimental CJD transmitted via the eye with infected cornea. N Engl J Med:1334–1337
Carp RI (1982) Transmission of scrapie by the oral route: effect of gingival scarification. Lancet:170–171
Brown P, Gibbs CJ Jr, Rodger-Johnson P et al. (1994) Human spongiform encephalopathy: The National Institutes of Health Series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529
Fraser JR (1996) Infectivity in extraneural tissues following intraocular scrapie infection. J Gen Virol 77:2663–2668
Ingrosso L, Pisani F, Pocchiari M (1999) Transmission of the 263 K scrapie agent by the dental route. J Gen Virol 80:3043–3047
Antloga K, Meszaros J, Malchesky PS, McDonnel GE (2000) Prion disease and medical devices. ASAIO J 46:69–72
Schulz-Schaeffer WJ, Beekes W, Kretzschmar H (2001) Die Pathophysiologie von Prionkrankheiten nach peripherer Übertragung. In: Hörnlimann B, Riesner D, Kretzschmar H (Hrsg) Prionen und Prionkrankheiten. De Gruyter, Berlin, S231–235
Sautereau D, Palazzo L (2001) Pinces à biopsie à usage unique en endoscopie digestive: sage décision ou caricature du principe de précautation? Gastroenterol Clin Biol 25:653–655
Verjat D, Prognon P, Darbold JC (1999) Fluorescence-assay on traces of protein on re-usable medical devices: cleaning efficiency. Int J Pharm 179:267–271
Brown P, Rohwer RG, Green EM, Gajdusek DC (1982) Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 145:683–687
Brown P, Rohwer RG, Gajdusek DC (1986) Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 153:1145–1148
Rohwer RG (1984) Virus-like sensitivity of scrapie agent to heat inactivation. Science 223:600–602
Rights and permissions
About this article
Cite this article
Die Variante der Creutzfeldt-Jakob-Krankheit (vCJK). Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 45, 376–394 (2002). https://doi.org/10.1007/s00103-002-0393-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-002-0393-4